MeSH D007634 - keratitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Dexamethasone | Dexamethasone |  | 1990-08-31 |  |  |
| Padagis | Dexamethasone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Dexamethasone |  | 1989-07-31 |  |  |
| Dexamethasone, Tobramycin | Tobramycin Dexamethasone |  | 2022-02-11 |  |  | |
| Mylan | Dexamethasone | Dexamethasone |  | 2008-08-29 |  |  |
| Sandoz | Dexamethasone | Dexamethasone |  | 1985-01-16 |  |  |
| Dexamethasone, Neomycin, Polymyxin b | Maxitrol |  | 1984-05-22 |  |  | |
| Dexamethasone, Ciprofloxacin | Ciprodex | 2025-06-04 | 2003-07-18 |  |  | |
| Dexamethasone, Tobramycin | Tobradex |  | 1988-08-18 |  |  | |
| AbbVie | Dexamethasone | Ozurdex | 2023-01-09 | 2009-06-17 | $488 M | Q2/23-Q1/24 |
| Novartis | Dexamethasone, Neomycin, Polymyxin b | Dexacidin |  | 1984-10-29 |  |  |
| Dexamethasone, Tobramycin | Tobradex |  | 1988-09-28 |  |  | |
| Wyeth | Dexamethasone | Dexamethasone |  | 1982-01-01 |  |  |
| UCB | Dexamethasone | Dexacort |  | 1982-01-01 |  |  |
| Alpharma | Dexamethasone | Dexamethasone |  | 1986-10-10 |  |  |
| Bausch Health Companies | Loteprednol etabonate | Alrex |  | 1998-03-09 |  |  |
| Dexamethasone | Dexamethasone |  | 1996-07-26 |  |  | |
| Dexamethasone, Neomycin, Polymyxin b | Dexasporin |  | 1995-09-13 |  |  | |
| Loteprednol etabonate | Lotemax |  | 1998-03-09 |  |  | |
| Loteprednol etabonate | Lotemax Sm | 2036-01-26 | 2019-02-22 |  |  | |
| Dexamethasone, Neomycin | Neomycin Dexamethasone |  | 1995-10-30 |  |  | |
| Dexamethasone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Dexamethasone |  | 1994-07-25 |  |  | |
| Dexamethasone, Tobramycin | Tobramycin Dexamethasone |  | 1999-10-27 |  |  | |
| Tobramycin, Loteprednol etabonate | Zylet |  | 2004-12-14 |  |  |
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
100%2/2
Phase 3
38%13/34
Approved: 9Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use